Evidence map›Paper›PMID 24779419›Full record

ArticleBrain pathology (Zurich, Switzerland)2014

Huntington's disease (HD): degeneration of select nuclei, widespread occurrence of neuronal nuclear and axonal inclusions in the brainstem.

Udo Rüb, Matthias Hentschel, Katharina Stratmann, Ewout Brunt, Helmut Heinsen, Kay Seidel, Mohamed Bouzrou, Georg Auburger, Henry Paulson, Jean-Paul Vonsattel and 3 more

Open access · greenAbstract read
In one paragraph

Article in Brain pathology (Zurich, Switzerland), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 1 pooled it
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 1 synthesis or guideline pooled it, 62 citations in OpenAlex.

  1. Systemic Symptoms in Huntington's Disease: A Comprehensive Review.Movement disorders clinical practice · 2024
    Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Disordered Decision Making: A Cognitive Framework for Apathy and Impulsivity in Huntington's Disease.Movement disorders : official journal of the Movement Disorder Society · 2022
    Review
  9. Article
  10. Juvenile-Onset Huntington Disease Pathophysiology and Neurodevelopment: A Review.Movement disorders : official journal of the Movement Disorder Society · 2022
    Review
  11. Review
  12. Article
  13. New Avenues for the Treatment of Huntington's Disease.International journal of molecular sciences · 2021
    Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 3 countries.

Udo RübDr. Senckenberg Chronomedical Institute, Goethe-University, Frankfurt/Main, Germany.
Matthias Hentschel
Katharina Stratmann
Ewout Brunt
Helmut Heinsen
Kay Seidel
Mohamed Bouzrou
Georg Auburger
Henry Paulson
Jean-Paul Vonsattel
Herwig Lange
Horst-Werner Korf
Wilfred den Dunnen
Goethe University Frankfurt · DESenckenberg Research Institute and Natural History Museum Frankfurt/M · DEUniversity Medical Center Groningen · NLNewYork–Presbyterian Hospital · USUniversity of Michigan–Ann Arbor · US

Funding

Mechanisms of Polyglutamine NeurodegenerationR01NS038712 · NINDS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI PAULSON, HENRY L · 2000 to 2019
$8.1M
NINDS NIH HHS R01 NS038712NINDS NIH HHS R01NS038712
6 · The paper itself

Abstract

Huntington's disease (HD) is a progressive polyglutamine disease that leads to a severe striatal and layer-specific neuronal loss in the cerebral neo-and allocortex. As some of the clinical symptoms (eg, oculomotor dysfunctions) suggested a degeneration of select brainstem nuclei, we performed a systematic investigation of the brainstem of eight clinically diagnosed and genetically confirmed HD patients. This post-mortem investigation revealed a consistent neuronal loss in the substantia nigra, pontine nuclei, reticulotegmental nucleus of the pons, superior and inferior olives, in the area of the excitatory burst neurons for horizontal saccades, raphe interpositus nucleus and vestibular nuclei. Immunoreactive intranuclear neuronal inclusions were present in all degenerated and apparently spared brainstem nuclei and immunoreactive axonal inclusions were observed in all brainstem fiber tracts of the HD patients. Degeneration of brainstem nuclei can account for a number of less well-understood clinical HD symptoms (ie, cerebellar, oculomotor and vestibular symptoms), while the formation of axonal aggregates may represent a crucial event in the cascades of pathological events leading to neurodegeneration in HD.

Indexed as

Adaptor Proteins, Signal TransducingAdultAgedAged, 80 and overAxonsBrain StemFemaleHumansHuntingtin ProteinHuntington DiseaseIntranuclear Inclusion BodiesMaleMiddle AgedNerve Tissue ProteinsNeuronsSequestosome-1 ProteinAdaptor Proteins, Signal TransducingHTT protein, humanHuntingtin ProteinNerve Tissue ProteinsSequestosome-1 ProteinSQSTM1 protein, humanUbiquitinaxonal inclusionsbrainstemHuntington's diseaseneurodegenerationpathoanatomypolyglutamine diseases

Identifiers

PMID24779419
PMCPMC4160739
OpenAlexW2130191396

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.